Edition:
United Kingdom

Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

13.75USD
19 Sep 2018
Change (% chg)

-- (--)
Prev Close
$13.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
51,398
52-wk High
$30.70
52-wk Low
$12.48

Chart for

About

Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through the development of pharmaceutical products on its own behalf or in collaboration with others. The Company's deuterated chemical entity platform... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $347.34
Shares Outstanding(Mil.): 22.69
Dividend: --
Yield (%): --

Financials

  CNCE.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -2.22 -- --
ROI: -45.62 1.78 14.61
ROE: -58.35 3.27 16.33

BRIEF-Concert Pharmaceuticals Reports Q1 Loss Per Share $0.19

* CONCERT PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

03 May 2018

BRIEF-Concert Pharmaceuticals Completes Enrollment In Phase 2A Trial Of CTP-543 In Alopecia Areata

* CONCERT PHARMACEUTICALS COMPLETES ENROLLMENT IN PHASE 2A TRIAL OF CTP-543 IN ALOPECIA AREATA

25 Apr 2018

Earnings vs. Estimates